A 77-year-old man, with a long history of idiopathic Parkinson's disease, was reviewed in the movement disorder clinic of the James Cook University Hospital. He had first presented to the neurological services 17 years previously with an asymmetrical, progressive upper limb tremor and associated rigidity. He had an otherwise unremarkable medical history. He had had a good and sustained response to l-dopa and dopamine agonists over the years, although increasing doses were ultimately limited by the late development of dyskinesia, somnolence and visual hallucinations. No atypical features were noted at first presentation, or on subsequent follow-up.
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Fourteen years after the diagnosis, in 2004, he began to deteriorate with falls and worsening mobility. His swallowing also became more difficult, with subsequent aspiration, fear of eating and weight loss. A percutaneous endoscopic gastrostomy (PEG) tube was placed, without complication, and to good effect.
In the 12 months prior to admission, and pre-dating PEG insertion by six months, he described ''choking'' episodes when asleep, about six times a night and becoming more frequent. His carer described noisy nocturnal inspiration and expiration when asleep, and paroxysms when he would ''go white, then red and blue and his eyes would bulge out.'' He found these episodes very distressing. In addition, he complained of daytime somnolence and his carer described pugilistic limb movements while asleep, suggestive of REMsleep behaviour disorder. Medication at this time consisted of l-dopa (Sinemet), amantadine, citalopram, low-dose amitriptyline, omeprazole and a buprenorphine patch for arthritic pain. There had been no exposure to atypical neuroleptics or anti-emetics. There were no symptoms of gastro-oesophageal reflux and the episodes did not obviously relate to ''wearing off'' periods.
COMMENT
The clinical history suggested some form of intermittent nocturnal upper airways obstruction, perhaps ''stridor'', based on the carer's description. The frequency of attacks prompted admission for further evaluation. The patient was nursed in a room with video monitoring to allow accurate characterisation of the events. Vital signs on admission were normal with peripheral oxygen saturation of 98% on room air. He had a 10-15 mm Hg drop in lying/standing blood pressure. Both his chest x ray and 12-lead ECG were normal.
Direct laryngeal examination during the day revealed normal vocal cord movement in expiration and inspiration. Overnight observation revealed multiple dyspnoeic attacks, predominantly beginning from a state of sleep, preceded by stridorous noises and culminating in complete airway obstruction (see online video). During these episodes, peripheral oxygen saturation dropped to 78% with a paO 2 of 6.31 and paCO 2 of 5.79 kPa on arterial blood case sampling (paO 2 8.98 and paCO 2 5.43 kPa during the day).
It was clear from the preliminary investigations that the problem was only at night, and almost exclusively occurred from a state of sleep. The normal direct laryngoscopy during the day ruled out a ''fixed'' structural disorder of the upper airway. Therefore, laryngoscopy was repeated in the late evening when it revealed paradoxical adduction of the vocal cords during inspiration. We made a working diagnosis of recurrent, nocturnal laryngeal dystonia.
We considered the possibility that the stridor was related to ''wearing off'' of antiparkinsonian treatment overnight. Although this cannot be completely ruled out, the patient exhibited marked ''wearing off'' during the day as well, without any respiratory symptoms. There are reports of gastro-oesophageal reflux causing similar symptoms, but the patient was already on a proton-pump inhibitor and had none of the familiar reflux symptoms such as ''heartburn.'' A comprehensive review of past drug-exposure revealed no medications likely to cause drug-induced laryngeal dystonia.
We considered using clonazepam at night or botulinum toxin injection into the cricoarytenoid muscles to treat the stridor and also discussed the potential role of non-invasive positive pressure ventilation in this situation. However, due to the increasing frequency and severity of the attacks, semi-urgent tracheostomy was undertaken with complete resolution of the hypoxaemic episodes.
Upper airways obstruction is highly unusual in Parkinson's disease but it is one of the hallmarks of multiple system atrophy. For this reason, we undertook investigations to look at this possibility further. Formal autonomic function tests, off amitriptyline, showed significant symptomatic orthostatic hypotension (33 systolic/32 diastolic mm Hg drop over three minutes) but the patient was unable to complete further autonomic assessment due to tremor and fatigue. A cardiac radioisotope scan using iodine-131-meta-iodobenzylguanidine (MIBG)
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Question 3
Is this an uncommon complication of a common condition, or a common complication of an uncommon condition? was abnormal, suggesting postganglionic degeneration of cardiac sympathetic innervation-a pattern seen most commonly in Parkinson's disease rather than multiple system atrophy. We therefore feel that the original diagnosis of Parkinson's disease was correct, making the occurrence of paroxysmal nocturnal laryngeal dystonia noteworthy.
Complaints of breathlessness are not uncommon in Parkinson's disease and can be accounted for by a range of factors including concomitant medical conditions, ''wearing off'' effects of dopaminergic therapies, anxiety, altered perception of dyspnoea, complications of ergot-derived dopamine agonists and physical deconditioning. Although stridor and severe respiratory compromise are well-recognised complications of another synucleinopathy, multiple system atrophy, 1, 2 it has seldom been reported in idiopathic Parkinson's disease. [3] [4] [5] By contrast, in multiple system atrophy, both focal laryngeal dystonia and vocal cord paresis have been implicated in the development of stridor. 6, 7 Terminology can be confusing with the terms laryngospasm, vocal cord abductor paralysis, adductor laryngeal breathing dystonia and focal laryngeal dystonia all used in the literature.
In multiple system atrophy, several small case series have demonstrated paradoxical vocal cord movement in patients with nocturnal stridor. 8, 9 Although many of these patients had normal vocal cord studies when awake, virtually all demonstrated paradoxical cord movements, or even paralysis, when sleep was induced with benzodiazepines. EMG studies have illustrated that it is dystonia, not paralysis which causes the stridor in these cases. 3 Such diurnal variation parallels that seen in our case of Parkinson's disease, with normal vocal cord movement early in the day and paradoxical movements becoming apparent in the late evening. We could detect no association with ''wearing off'' of antiparkinsonian medications, as has been reported in a previous case. 4 Although continuous positive airway pressure (CPAP) ventilation 2 and even botulinum toxin injection 3 have been used in the treatment of such symptoms in multiple system atrophy, we decided on tracheostomy due to the frequency and severity of the attacks. This treatment has been used with good success in many patients with multiple system atrophy in the past, and resulted in complete resolution of symptoms and a reduction in daytime somnolence in our patient.
Because of the paucity of documented cases of idiopathic Parkinson's disease causing this complication, we revisited the diagnosis and undertook additional investigations to rule out an atypical extrapyramidal disorder. The long clinical course of our patient's illness, with drug-induced dyskinesias and sustained l-dopa response, argue in favour of idiopathic Parkinson's disease. Autonomic function tests were uninformative due to difficulties in performing the specific tasks required. Furthermore, cardiac MIBG scanning revealed the postganglionic sympathetic degeneration typical of Parkinson's disease and not frequently seen in multiple system atrophy. 10 In summary, paroxysmal noctural laryngeal dystonia is a rare complication of idiopathic Parkinson's disease, but one with potentially devastating clinical consequences if left untreated.
